Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Rejetto HFS servers now actively scanned for critical RCE flaw

Hackers are actively scanning for a Rejetto HFS weak signing key vulnerability, tracked as CVE-2026–61500, that allows session forgery, account takeover, and remote code execution (RCE).

VulnCheck VP of Security Research Caitlin Condon posted on LinkedIn over the weekend that the company’s Canary Intelligence honeypots had observed probes targeting CVE-2026–61500.

Condon said the observed activity appears to be small-scale reconnaissance from a single China Telecom IP address probing deployments in Japan and the United States.

New Dell System Update flaw lets hackers gain root privileges

Dell warned customers to patch a critical vulnerability in the System Update (DSU) command-line interface (CLI) deployment tool as soon as possible.

DSU lets enterprise IT administrators deploy BIOS, firmware, and software updates onto Linux and Windows systems on PowerEdge enterprise server infrastructure.

In a Thursday security advisory, the company said the flaw (tracked as CVE-2026–86360) allows threat actors to execute code with root privileges on unpatched devices by exploiting a path traversal weakness.

Microsoft: Windows KB5124010 update crashes some games and apps

Microsoft confirmed over the weekend that some games and applications using AC-3 (Dolby Digital) audio decoding will crash after installing the September 2026 KB5124010 Windows 11 preview update.

KB5124010 is an optional update that requires users to click the “Download and install” link, which should reduce the number of potentially affected Windows users. However, it installs automatically on devices running Windows 11 24H2, where the “Get the latest updates as soon as they’re available” option is toggled on.

“In some cases the application can fail to launch, or close without warning. In other cases the application will work normally until certain features are used, such as playing music,” Microsoft said in a Friday update to the Windows release health dashboard. “Affected applications may vary and can include games, media players, and certain productivity applications.”

Anthropic Compute Spend Outpaced Its Own 2025 Revenue

A leaked draft of Anthropic’s IPO prospectus shows the company spent $7.33 billion on compute and infrastructure in 2025 against $4.6 billion in revenue — roughly $1.60 of infrastructure for every dollar earned.

Operating losses exceeded $8 billion. Long-term cloud and infrastructure commitments total $518 billion over the next decade.

Revenue is accelerating: Q2 2026 alone hit $11.5 billion, more than the entire previous year, and the company reports operating profit in recent quarters.

The number that matters for buyers is the spend-to-revenue ratio. Every enterprise building long-term plans around a frontier AI vendor’s API pricing is implicitly betting that the vendor’s own infrastructure math holds.

Before locking multi-year contracts, ask vendors for their compute-spend-to-revenue ratio — not just today’s price per token.

Full analysis:

#AIEconomics #Anthropic #AIInfrastructure #Procurement

Human tau seeds trigger disease-specific shapes in mouse brains, new study finds

Tau is a protein that occurs naturally in the brain. It is essential for proper neuron development and for how neurons communicate with each other. The same protein, however, when misshapen or misfolded, can act as a driver of neurodegenerative diseases. Abnormal buildup of tau is a hallmark of Alzheimer’s disease, and scientists have also found an association between misfolded tau and more than 20 neurodegenerative diseases.

The prominent prion hypothesis proposes that misfolded proteins spread by forcing normally shaped proteins to copy their exact 3D structure. To test its validity, a recent study investigated at the atomic level how misfolded tau proteins spread and multiply through the brain.

Researchers injected tiny amounts of human tau seeds from Alzheimer’s disease (AD) or corticobasal degeneration (CBD) into the brains of healthy mice. High-resolution microscopy that captured tau at the atomic level revealed that the mice’s own tau had misfolded into exact 3D structural copies of the diseased original seeds. The human seeds vanished within a week, but not before setting off a chain reaction in which the mice’s tau continued to form fibers with matching disease-specific folds and accumulate for the next nine to 12 months.

New study investigates PFAS exposure and future inflammatory bowel disease

Exposure to per- and polyfluoroalkyl substances (PFAS), often called “forever chemicals,” may play a role in the development of inflammatory bowel disease (IBD) years before symptoms appear, according to a new five-year study supported by a $3.3 million National Institutes of Health (NIH) R01 grant to researchers at the Icahn School of Medicine at Mount Sinai.

Mount Sinai Researchers Identify How APOE4 Gene Damages Brain Blood Vessels in Alzheimer’s Disease

About the Mount Sinai Health System

Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.

As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.

Michelle Odemwingie on AI in Education | Goalkeepers 2026

A test score can show what a student understands, but it doesn’t always tell the full story.

As a former educator, Michelle Odemwingie learned this firsthand in her own classroom. Now, as CEO of Achievement Network, she’s using data and AI to give teachers clearer insights into student development and help them tailor learning to each student’s unique needs.

Hear her powerful story about helping students learn and feel authentically seen: https://youtu.be/Td6qbAPnhx4

#WorldTeachersDay


What if a test could tell a teacher more than what a student got wrong?

Millisecond-timescale, genetically targeted optical control of neural activity

Karl Deisseroth just won the Nobel Prize.

He showed that brain cells can be turned on/off by shining blue light on them, after inserting a light-sensitive protein from algae.

The method was named optogenetics and has been used worldwide to link specific neural circuits to behavior.

But Ed Boyden is the main author of this paper? I was wondering.

It’s a question many people in neuroscience are asking today, and there are a few layers to it.

First, what the prize actually honors. The 2026 Nobel in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann, and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics” — essentially two scientific contributions: discovering the light-gated ion channel (Hegemann and Nagel’s channelrhodopsin work in the early 2000s) and turning it into a tool for controlling neurons (Deisseroth). Boyden’s name does appear in the Nobel committee’s own advanced documentation, which explicitly describes the 2005 paper as work by “Deisseroth, Nagel and collaborators” — the committee treats Deisseroth as the driving scientific force behind the neural-control half of the discovery.

Second, why first authorship doesn’t settle it. In the 2005 paper (Boyden, Zhang, Bamberg, Nagel, Deisseroth), Boyden was the first author, but Deisseroth was the senior/last author — meaning it was his lab, his conception of the project, and his scientific program. Nobel committees don’t reward authorship order; they try to identify who originated the decisive insight. Boyden was a graduate student at the time, doing the experiments within Deisseroth’s research program (Boyden himself has described working first in Richard Tsien’s lab, then moving into Deisseroth’s new Stanford lab in spring 2005).

FieldAI Robot Brain Hits A $10 Billion Valuation

FieldAI has raised $700 million at a $10 billion valuation — more than quadrupling its worth in just over a year.

The company builds no robots. It sells a “universal general-purpose brain” designed to run humanoids, drones, robot dogs and industrial rovers across different hardware platforms.

The thesis is clear: robot hardware will keep commoditizing. The durable value sits in the intelligence layer that can control many bodies.

FieldAI now has more than $135 million in revenue and customer contracts, with $35 million added since June. Backers include Nvidia, Intel, and Hyundai Motor Group.

It sits in a three-way race with Physical Intelligence (~$11B) and Skild AI (~$14B) to own that layer.

For buyers the question is shifting: do you buy a robot whose intelligence is locked to one manufacturer, or one running a third-party brain that can move across platforms later? The second option buys flexibility — and adds a new vendor dependency.

Full analysis:

/* */